Dobot (Yuejiang Technology), the world’s top collaborative-robot maker by sales, is heading to a ChiNext IPO. After listing on the Hong Kong exchange in December 2024 and closing two H-share placements worth about 1.8 billion Hong Kong dollars, the company confirmed its Shenzhen listing plan in December 2025 and finished IPO tutoring in April 2026. Its ChiNext application was accepted just 17 days after a CSRC reform opinion and now goes before the listing committee, a full cycle of under three months.
Dobot plans to raise 1.2 billion yuan, allocating 550 million to multi-legged robot R&D and industrialisation, 250 million to humanoid-robot technology, 100 million to marketing, and 300 million to working capital. With rival Jaka’s Sci-Tech Board IPO terminated in late 2025, Dobot stands to claim the title of A-share cobot first listing, a capstone on a funding arc that runs from collaborative arms up to humanoids and multi-legged embodied robots.
Why the timing works
The policy window is the quiet driver. A June 2025 opinion on deepening Shenzhen’s comprehensive reform allowed Greater Bay companies already listed in Hong Kong to list in Shenzhen, and an April 2026 CSRC opinion actively supported quality but unprofitable innovators on ChiNext. Dobot fits both, turning regulatory change into a capital ladder that funds the jump from cobots to full embodied-robot product lines.
For European factories and automation buyers, the practical read is supply side: the global collaborative-robot leader is now financed to scale its humanoid and multi-legged lines quickly, tightening an already competitive sourcing market where Chinese cobot makers set the volume and price benchmarks.
Read the original report (in Chinese)
*Translated and adapted from Ofweek Robotics (https://robot.ofweek.com/2026-07/ART-8321202-8120-30694825.html).*